NCT03340649

The Predictive Value of Hepatocyte Growth Factor and Soluble Receptor s-Met in Sepsis

The Predictive Value of Hepatocyte Growth Factor and Soluble Receptor s-Met in Evaluating Sepsis Patient's Disease Severity and Prognosis

• Status: Unknown
• Phase: —
• Study type: Observational
• Enrollment: 90 (estimated)
• Sponsor: Jingyuan,Xu · Academic / Other
• Sex: All
• Age: 18 Years – 80 Years
• Healthy volunteers: Not accepted

Summary

To observe the changes of plasma hepatocyte growth factor and soluble receptor s-Met levels in patients with sepsis, and to explore its clinical significance.

Detailed description

90 patients who diagnosed as sepsis were included in this study. Then keep blood samples from these patients in the first day, the third day, detect the hepatocyte growth factor and soluble receptor s-Met level in plasma byenzyme-linked immuno sorbent assay. Record Severity of illness and survival status of every patient within 28 days. Objective to evaluate the correlation between the level of hepatocyte growth factor and soluble receptor s-Met in plasma and the prognosis of the patients.

Conditions

• Sepsis

Interventions

Type	Name	Description
OTHER	taking peripheral blood	taking peripheral blood of no more than 3ml

Timeline

• Start date: 2017-11-09
• Primary completion: 2017-11-09
• Completion: 2018-03-01
• First posted: 2017-11-13
• Last updated: 2017-11-13

Locations

1 site across 1 country: China